M. Docteur GUILLAUME CHEVREL
22ans d'exercice (thèse 2004)
✨ Profil synthétique
IA · 30/04/2026Le Dr Guillaume Chevrel est un rhumatologue à Saint-Nazaire avec une solide formation en immunologie. Il a une production scientifique importante, avec un h-index de 23 et 297 publications, principalement axées sur les réactions indésirables aux médicaments, les troubles du sang et le traitement du cancer. Ses travaux de recherche et ses publications PubMed montrent une expertise dans les essais cliniques et l'épidémiologie, notamment en ce qui concerne les csDMARDs.
Expertises présumées
- Essais cliniques
- csDMARDs
- Épidémiologie
- Réactions indésirables aux médicaments
- Troubles du sang
- Leucémie lymphocytique chronique
- Cancérologie
- Pharmacologie
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎯 Capacités
- Aide médicale urgente (CAPA)
🎓 Diplômes
- DE Docteur en médecine
📝 Autres formations
- Aide médicale urgente
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
23
h articles cités ≥ h fois chacun. Un h de 23 = 23 publications avec 23+ citations.
Citations
3 108
Publications
297
i10-index
38
Thématiques principales
- Chemistry and Stereochemistry Studies ×83
- Drug-Induced Adverse Reactions ×33
- Blood disorders and treatments ×32
- Chronic Lymphocytic Leukemia Research ×24
- Cancer Treatment and Pharmacology ×24
Affiliations FR : Hôpital Avicenne
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trial
2026ArticleCritical Care
Biomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO study
2025ArticleCritical Care
Study protocol and statistical plan for the ICRAKI trial: Intermittent haemodialysis versus continuous renal replacement therapy for severe acute kidney injury in critically ill patients
2025ArticleCritical care and resuscitation
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024
2024ArticleAnnals of Intensive Care
Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: a secondary analysis of a multicenter randomized controlled trial
2024ArticleIntensive Care Medicine
Long-term outcomes after severe acute kidney injury in critically ill patients: the SALTO study
2023ArticleAnnals of Intensive Care
Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial
2023ArticleIntensive Care Medicine
A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial
2022ArticleCritical Care
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Livres & ouvrages
300 médicaments injectables
2011 · Elsevier Masson · 596 p.
avec Virginie Dessus
- 📕
Interactions cellulaires et cytokines dans les myosites inflammatoires idiopathiques
2004 · 214 p.
avec Pierre Miossec
- 📕
L'ostéogenèse imparfaite de l'adulte
étude absorptiométrique et thérapeutique
1996
Source : Google Books — filtre catégories médicales/santé/sciences.
Localisation
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
CABINET DU DR GUILLAUME CHEVREL
5 RUE DES TROENES, 44600 Saint-Nazaire
Libéral© OpenStreetMapCH DE SAINT NAZAIRE
CITE SANITAIRE GEORGES CHARPAK — 11 Boulevard GEORGES CHARPAK, 44606 Saint-Nazaire
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit
The New England journal of medicine · 2016
- 2Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial
Lancet (London, England) · 2021
📚 180 citations🎯 RCR 13.50Top 2% NIH🩺 Clinique - 3Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells
Arthritis and rheumatism · 2004
📚 111 citations🎯 RCR 2.38Top 22% NIH
Publications scientifiques (34) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal22
▼
Transversal22
▼- Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trial
Critical care (London, England) · 2026 · Journal Article
Picod A, Boussier J, Tubiana S, Louis G, et al.
- Risk, rate or rhythm control for new onset supraventricular arrhythmia during septic shock: protocol for the CAFS multicentre, parallel-group, open-label trial
BMJ open · 2025 · Journal Article
Labbé V, Desnos C, Preau S, Doyen D, et al.
🩺 Clinique - Biomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO study
Critical care (London, England) · 2025 · Journal Article
Chaïbi K, Picod A, Boubaya M, Tubiana S, et al.
📚 5 cit.🎯 RCR 2.01 - Study protocol and statistical plan for the ICRAKI trial: Intermittent haemodialysis versus continuous renal replacement therapy for severe acute kidney injury in critically ill patients
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2025 · Journal Article
Gaudry S, Boubaya M, Louis G, Chaïbi K, et al.
📚 1 cit. - Long-term outcomes after severe acute kidney injury in critically ill patients: the SALTO study
Annals of intensive care · 2023 · Journal Article
Chaïbi K, Ehooman F, Pons B, Martin-Lefevre L, et al.
📚 20 cit.🎯 RCR 3.11 - Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies
Critical care (London, England) · 2022 · Journal Article
Gaudry S, Grolleau F, Barbar S, Martin-Lefevre L, et al.
📚 62 cit.🎯 RCR 6.36🩺 Clinique - High Heterogeneity of Temporal Bone CT Aspects in Osteogenesis Imperfecta Is Not Linked to Hearing Loss
Journal of clinical medicine · 2022 · Journal Article
Ltaief-Boudrigua A, Lina-Granade G, Truy E, Hermann R, et al.
📚 2 cit. - Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit
The New England journal of medicine · 2016 · Journal Article
Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, et al.
📚 823 cit.🎯 RCR 36.95🩺 Clinique - Difficult peripheral venous access: clinical evaluation of a catheter inserted with the Seldinger method under ultrasound guidance
Journal of critical care · 2014 · Evaluation Study
Meyer P, Cronier P, Rousseau H, Vicaut E, et al.
📚 24 cit.🎯 RCR 1.32🩺 Clinique - Evaluation of blind nasotracheal suctioning and non-bronchoscopic mini-bronchoalveolar lavage in critically ill patients with infectious pneumonia: a preliminary study
Respiratory care · 2014 · Evaluation Study
Meyer P, Rousseau H, Maillet JM, Thierry S, et al.
📚 10 cit.🔬→🩺 Translationnel - Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis
Arthritis and rheumatism · 2012 · Journal Article
Eljaafari A, Tartelin ML, Aissaoui H, Chevrel G, et al.
📚 71 cit.🎯 RCR 1.97 - Beneficial effects of loxapine on agitation and breathing patterns during weaning from mechanical ventilation
Critical care (London, England) · 2010 · Journal Article
Sztrymf B, Chevrel G, Bertrand F, Margetis D, et al.
📚 12 cit.🔬→🩺 Translationnel - Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations
Bone · 2010 · Journal Article
Rousseau JC, Chevrel G, Schott AM, Garnero P
📚 12 cit. - Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations
Bone · 2009 · Journal Article
Garnero P, Schott AM, Prockop D, Chevrel G
📚 25 cit.🔬→🩺 Translationnel - Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2007 · Clinical Trial
Ricard JD, Wolff M, Lacherade JC, Mourvillier B, et al.
📚 97 cit.🎯 RCR 3.25🩺 Clinique - Fractures and handicap in an adult population: A clinical study
Joint bone spine · 2007 · Journal Article
Chevrel G, Limouzin A, Garnero P, de Montalivet C, et al.
📚 3 cit. - Osteogenesis imperfecta: new treatment options
Current rheumatology reports · 2006 · Journal Article
Chevrel G, Cimaz R
📚 4 cit. - Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells
Arthritis and rheumatism · 2004 · Journal Article
Page G, Chevrel G, Miossec P
📚 111 cit.🎯 RCR 2.38🔬→🩺 Translationnel - Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation
Annals of the rheumatic diseases · 2002 · Journal Article
Chevrel G, Garnero P, Miossec P
📚 23 cit. - Focal myositis: a new HLA-DR4 0401 associated disease?
The Journal of rheumatology · 1999 · Case Reports
Caunes O, Chevrel G, Miossec P
📚 3 cit. - Severe uveitis followed by reactive arthritis after bacillus Calmette-Guérin therapy
The Journal of rheumatology · 1999 · Case Reports
Chevrel G, Zech C, Miossec P
📚 27 cit.🎯 RCR 1.11🔬→🩺 Translationnel - Bacillus Calmette-Guérin induced aseptic arthritis: an experimental model of reactive arthritis
The Journal of rheumatology · 1998 · Editorial
Buchs N, Chevrel G, Miossec P
📚 25 cit.
Essai clinique8
▼
Essai clinique8
▼- Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: a secondary analysis of a multicenter randomized controlled trial
Intensive care medicine · 2024 · Journal Article
Rambaud T, Hajage D, Dreyfuss D, Lebbah S, et al.
📚 10 cit.🎯 RCR 2.08🔬→🩺 Translationnel - Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial
Intensive care medicine · 2022 · Journal Article
Labro G, Tubach F, Belin L, Dubost JL, et al.
📚 13 cit.🎯 RCR 1.26🩺 Clinique - Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial
Lancet (London, England) · 2021 · Journal Article
Gaudry S, Hajage D, Martin-Lefevre L, Lebbah S, et al.
📚 180 cit.🎯 RCR 13.50🩺 Clinique - Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial
Annals of intensive care · 2021 · Journal Article
Benichou N, Lebbah S, Hajage D, Martin-Lefèvre L, et al.
📚 10 cit.🔬→🩺 Translationnel - The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trial
Trials · 2019 · Clinical Trial Protocol
Gaudry S, Hajage D, Martin-Lefevre L, Louis G, et al.
📚 13 cit.🩺 Clinique - Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome. A Post Hoc Analysis of the AKIKI Randomized Clinical Trial
American journal of respiratory and critical care medicine · 2018 · Journal Article
Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, et al.
📚 66 cit.🎯 RCR 2.90🩺 Clinique - Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI)
Trials · 2015 · Comparative Study
Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, et al.
📚 20 cit.🩺 Clinique - Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2006 · Journal Article
Chevrel G, Schott AM, Fontanges E, Charrin JE, et al.
📚 71 cit.🎯 RCR 2.22🩺 Clinique
csDMARDs2
▼
csDMARDs2
▼- Allergic pancytopenia to trimethoprim-sulphamethoxazole for Pneumocystis carinii pneumonia following methotrexate treatment for rheumatoid arthritis
Rheumatology (Oxford, England) · 1999 · Case Reports
Chevrel G, Brantus JF, Sainte-Laudy J, Miossec P
📚 11 cit. - Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate: a kinetic study of lymph node changes
Arthritis and rheumatism · 1999 · Case Reports
Chevrel G, Berger F, Miossec P, Blanc M, et al.
📚 13 cit.
Épidémiologie & registres2
▼
Épidémiologie & registres2
▼- Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: a retrospective study
BMC infectious diseases · 2008 · Journal Article
Meybeck A, Ricard JD, Barnaud G, Eveillard M, et al.
📚 5 cit. - Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide
Rheumatology (Oxford, England) · 2001 · Journal Article
Chevrel G, Jenvrin C, McGregor B, Miossec P
📚 35 cit.🎯 RCR 1.09🔬→🩺 Translationnel
Datasets & protocoles partagés
Initial antibiotherapy prescribed to patients infected with
Image2011figshareA patient could receive more than one drug.<b>Copyright information:</b>Taken from "Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant in ICU: A retrospective study"http://www.b
Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies
Collection2022figshareAbstract Background Intermittent hemodialysis (IHD) and continuous renal replacement therapy (CRRT) are the two main RRT modalities in patients with severe acute kidney injury (AKI). Meta-analyses conducted more than 10
Long-term outcomes after severe acute kidney injury in critically ill patients: the SALTO study
Collection2024figshareAbstract Background The extent of the consequences of an episode of severe acute kidney injury (AKI) on long-term outcome of critically ill patients remain debated. We conducted a prospective follow-up of patients includ
Initial antibiotherapy prescribed to patients infected with
Image2011figshareA patient could receive more than one drug.<b>Copyright information:</b>Taken from "Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant in ICU: A retrospective study"http://www.b
Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial
Collection2021figshareAbstract Background Vascular access for renal replacement therapy (RRT) is routine question in the intensive care unit. Randomized trials comparing jugular and femoral sites have shown similar rate of nosocomial events a
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).